Protara Therapeutics, Inc. Preferred Stock, Value, Issued
Protara Therapeutics, Inc. (TARA) had Preferred Stock, Value, Issued of $8 as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Equity
us-gaap:PreferredStockValue · last filed 2020-11-12
- 2020-09-30: Preferred Stock, Value, Issued $8.00.
- 2020-06-30: Preferred Stock, Value, Issued $4.00.
- 2020-03-31: Preferred Stock, Value, Issued $4.00.
- 2018-06-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2020-09-30 | $8.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.00 10-Q · filed 2020-07-31 |
| 2020-03-31 | $4.00 10-Q · filed 2020-05-13 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-07 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-13 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |